Methoxetamine (MXE, 3-MeO-2'-oxo-PCE) is a synthetic dissociative anesthetic of the arylcyclohexylamine class, designed as a structural analog of ketamine with a 3-methoxy group added to the phenyl ring and an N-ethyl group replacing the methylamine nitrogen. MXE holds a unique and beloved place in dissociative community history — widely considered by its community of users to be among the most sophisticated and remarkable dissociative experiences available, occupying a category described as combining ketamine's dissociative depth with meaningful antidepressant aftereffects and a distinctive psychedelic dimension absent from ketamine.
MXE was developed and briefly popularized in the early 2010s before being scheduled in the UK in 2012 (the first novel psychoactive substance to receive emergency temporary class drug status in the UK) and subsequently in other jurisdictions. Its unavailability has become part of its legend — community members who used MXE in its accessible period frequently describe it in reverential terms, and it has served as a benchmark against which other dissociatives are compared. Community experience data, while now historical, is rich: users describe a warm, deeply introspective dissociation with pronounced music enhancement, sustained antidepressant effects lasting days to weeks after a single experience, and a visual and philosophical depth not typical of other arylcyclohexylamines.
Despite its celebrated status, MXE carried meaningful toxicity concerns — particularly cerebellar toxicity (ataxia, coordination problems) and reports of kidney damage with regular use, which distinguished its toxicity profile somewhat from ketamine. The concern about kidney toxicity (not just bladder toxicity as with ketamine) represents an important and underappreciated harm from the MXE era.
Safety at a Glance
High Risk- MXE as a Historical Reference
- Harm Reduction for Any Available MXE
- Toxicity: Cerebellar Toxicity MXE produced a distinctive neurological toxicity not prominent with ketamine: cerebellar dysfunct...
- Dangerous with: Alcohol, Desomorphine, GBL, GHB (+2 more)
- Overdose risk: Overdose on Methoxetamine can range from unpleasant to life-threatening depending on the dose, ro...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Dosage
insufflated
oral
Duration
insufflated
Total: 3 hrs – 5 hrsoral
Total: 4 hrs – 6 hrsHow It Feels
The first sign is a warmth that rises through the body like a tide of honey — thick, golden, and unmistakably alive. Within twenty minutes the warmth has reached the crown of the head and begun to overflow into perception itself: colors deepen, the air between objects acquires a faint luminosity, and sound takes on a richness and resonance that transforms even ordinary ambient noise into something approaching music. There is a magic to MXE's onset that is difficult to articulate and impossible to mistake — a sense of entering not just a different state of consciousness but a different world entirely, one that has been here all along, just behind the surface of things.
The come-up is where the compound's legendary character reveals itself. The dissociation builds alongside a serotonergic warmth that is wholly absent from ketamine and its analogues — a genuine emotional openness, a capacity for wonder and tenderness that makes the experience feel more like a psychedelic than a dissociative. Your body becomes light and flowing; movement feels graceful and effortless, as though you are being carried by a gentle current rather than propelling yourself. Sound is extraordinary — music seems to unfold in three dimensions, each note a physical object occupying space, and the silence between notes becomes as expressive as the notes themselves. The room breathes.
At the peak, MXE can produce a state that its devotees call the "M-hole" — a cousin of the ketamine hole but warmer, more narrative, more personally meaningful. Where ketamine's hole is geometric and impersonal, MXE's is mythological: vast interior landscapes populated by archetypes and symbols, journeys through imaginal spaces that feel as real and consequential as waking life. You may encounter presences, entities, vast intelligences that communicate through feeling rather than language. The emotional intensity can be overwhelming — not frightening, but so beautiful it hurts, a beauty that seems to contain all of grief and joy simultaneously. Time becomes irrelevant; a minute and an hour are the same thing.
The descent is gentle and carries a profound afterglow — a residual warmth and emotional openness that can persist for days. You return to your body gradually, like waking from a dream you wish you could continue. The world looks newly minted: fresh, vivid, pregnant with meaning. Sleep comes easily and is populated by extraordinary dreams. In the morning the afterglow remains, a quiet radiance, as though MXE has left a thin layer of gold leaf on everything it touched. This afterglow is perhaps the compound's most celebrated quality — the sense that something has been permanently, gently improved, a window opened that does not quite close.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(14)
- Decreased libido— Decreased libido is a diminished interest in and desire for sexual activity, commonly caused by subs...
- Dizziness— A sensation of spinning, swaying, or lightheadedness that impairs balance and spatial orientation, o...
- Increased libido— A marked enhancement of sexual desire, arousal, and sensitivity to erotic stimuli that can range fro...
- Motor control loss— A distinct decrease in the ability to control one's physical body with precision, balance, and coord...
- Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
- Orgasm suppression— Orgasm suppression (anorgasmia) is the difficulty or complete inability to achieve orgasm despite ad...
- Pain relief— A suppression of negative physical sensations such as aches and pains, ranging from dulled awareness...
- Perception of bodily lightness— Perception of bodily lightness is the subjective feeling that one's body has become dramatically lig...
- Physical autonomy— Physical autonomy is the experience of one's body performing actions — from simple tasks like walkin...
- Physical euphoria— An intensely pleasurable bodily sensation that can manifest as waves of warmth, tingling electricity...
- Sedation— A state of deep physical and mental calming that manifests as a progressive desire to remain still, ...
- Serotonin syndrome— Serotonin syndrome is a potentially fatal medical emergency caused by excessive serotonergic activit...
- Spatial disorientation— Spatial disorientation is the inability to accurately perceive one's position or orientation within ...
- Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
Tactile(2)
- Tactile distortion— Tactile distortion is the warping of existing touch and body sensations — textures may feel alien, p...
- Tactile suppression— A progressive decrease in the ability to feel physical touch, ranging from mild numbness to complete...
Cognitive & Perceptual Effects
Visual(14)
- Colour suppression— A visual effect in which the perceived saturation and vibrancy of colors is diminished, causing the ...
- Double vision— The visual experience of seeing a single object as two separate, overlapping images, similar to cros...
- Environmental cubism— A visual distortion in which the environment and objects within it appear fragmented into geometric,...
- External hallucination— A visual hallucination that manifests within the external environment as though it were physically r...
- Frame rate suppression— Perception of visual motion as choppy discrete frames rather than smooth continuous flow, resembling...
- Geometry— The experience of perceiving complex, ever-shifting geometric patterns superimposed over the visual ...
- Internal hallucination— Vivid, detailed visual experiences perceived within an imagined mental landscape that can only be se...
- Perspective distortions— Distortion of perceived depth, distance, and size of real objects, making things appear closer, furt...
- Perspective hallucination— A hallucinatory phenomenon in which the observer's visual perspective shifts from the normal first-p...
- Scenery slicing— The visual field fractures into distinct, cleanly cut sections that slowly drift apart from their or...
- Settings, sceneries, and landscapes— The perceived environment in which hallucinatory experiences take place, ranging from recognizable l...
- Visual acuity suppression— Vision becomes blurred, indistinct, and out of focus, as though looking through a smudged lens. Fine...
- Visual agnosia— A dissociative visual-cognitive effect in which the observer can physically see objects with normal ...
- Visual disconnection— A dissociative visual effect involving a progressive detachment from visual perception, ranging from...
Cognitive(21)
- Amnesia— A complete or partial inability to form new memories or recall existing ones during and after substa...
- Analysis suppression— Analysis suppression is a cognitive impairment in which the capacity for logical reasoning, critical...
- Anxiety— Intense feelings of apprehension, worry, and dread that can range from a subtle background unease to...
- Anxiety suppression— A partial to complete suppression of anxiety and general unease, producing a calm, relaxed mental st...
- Cognitive euphoria— A cognitive and emotional state of intense well-being, elation, happiness, and joy that manifests as...
- Compulsive redosing— An overwhelming, difficult-to-resist urge to continuously take more of a substance in order to maint...
- Conceptual thinking— A shift in the nature of thought from verbal, linear sentence structures to intuitive, non-linguisti...
- Creativity enhancement— An increase in the ability to imagine new ideas, overcome creative blocks, think about existing conc...
- Deja vu— Intense, often prolonged sensation of having already experienced the current moment, common with psy...
- Depersonalization— A detachment from one's own sense of self, body, or mental processes, as if observing oneself from o...
- Derealization— A perceptual disturbance in which the external world feels profoundly unreal, dreamlike, or artifici...
- Disinhibition— A marked reduction in social inhibitions, self-consciousness, and behavioral restraint that manifest...
- Dream potentiation— Enhanced dream vividness, complexity, and recall, often occurring as REM rebound after discontinuing...
- Immersion enhancement— A heightened capacity to become fully absorbed and engrossed in external media such as music, films,...
- Introspection— An enhanced state of self-reflective awareness in which one feels drawn to examine their own thought...
- Jamais vu— Jamais vu is the unsettling experience of encountering something deeply familiar — a word, a place, ...
- Mania— Abnormally elevated mood, energy, and activity with impulsive behavior and grandiosity, associated w...
- Memory suppression— A dose-dependent inhibition of one's ability to access and utilize short-term and long-term memory, ...
- Personal meaning enhancement— Personal meaning enhancement is a state in which everyday events, coincidences, song lyrics, environ...
- Thought deceleration— The experience of thoughts occurring at a markedly reduced pace, as if the mind has been placed into...
- Time distortion— Subjective perception of time becomes dramatically altered — minutes may feel like hours, or hours p...
Multi-sensory(2)
- Memory replays— Memory replays are vivid, multisensory re-experiences of past events that go far beyond normal recal...
- Scenarios and plots— Scenarios and plots are the narrative structures that emerge within hallucinatory states — coherent ...
Transpersonal(3)
- Ego death— A profound dissolution of the sense of self in which personal identity, memories, and the boundary b...
- Existential self-realization— A sudden, visceral realization of the profound significance and improbability of one's own existence...
- Unity and interconnectedness— A profound sense that identity extends beyond the self to encompass other people, nature, or all of ...
Pharmacology
Mechanism of Action
MXE acts as a non-competitive NMDA receptor antagonist and serotonin reuptake inhibitor. The dual pharmacology — NMDA antagonism plus SERT inhibition — is believed to underlie its distinctive effect quality compared to ketamine alone, contributing both to the enhanced mood and the qualitatively different experiential character.
The SERT inhibition is a pharmacologically meaningful distinction: it places MXE in a similar mechanistic category to ketamine (which also has some serotonergic activity) but with a more pronounced serotonergic component. This is likely responsible for the antidepressant aftereffect documented extensively by community members.
NMDA Antagonism Mechanism
Like ketamine, MXE blocks the NMDA receptor ion channel in a non-competitive, open-channel fashion. Binding studies indicate MXE has comparable or greater NMDA receptor affinity than ketamine, consistent with its approximately similar potency by weight.
Clarification of Opioid Activity
Despite early speculation (partly based on structural similarity to 3-HO-PCP), formal research has not supported significant opioid receptor activity for MXE. Community references to opioid-like warmth likely reflect serotonergic and NMDA mechanisms rather than true opioid receptor agonism.
Potency and Duration
MXE is approximately equivalent to ketamine in potency by weight (active doses 10–75 mg insufflated), with a longer duration — typically 3–5 hours — compared to ketamine's 1–1.5 hours. The longer duration reflects different pharmacokinetic handling.
Antidepressant Properties
The NMDA antagonism plus SERT inhibition combination may explain the extended antidepressant effects reported by community members. Ketamine's antidepressant mechanisms involve NMDA antagonism and downstream synaptic plasticity; SERT inhibition could augment or extend these effects.
Detection Methods
Standard Drug Panel Inclusion
Methoxetamine (MXE) is NOT included on standard 5-panel or 10-panel drug screens. It does not cross-react with standard PCP or ketamine immunoassays in most cases, though some PCP immunoassay platforms have shown variable, low-level cross-reactivity with MXE at high concentrations. Extended panels that specifically target MXE have been developed by some reference laboratories in response to its emergence as a drug of abuse, but these are not widely deployed.
Urine Detection
MXE is detectable in urine for approximately 2 to 5 days after a single dose. The compound is metabolized by O-demethylation to produce hydroxymethoxetamine and by N-deethylation to produce normethoxetamine. Both the parent compound and these metabolites are present in urine. The relatively long duration of action (3 to 5 hours) and the lipophilic arylcyclohexylamine structure contribute to an extended detection window. LC-MS/MS methods specifically targeting MXE and its metabolites are required for reliable detection.
Blood and Serum Detection
Blood detection windows are 1 to 3 days. Active blood concentrations in reported clinical and forensic cases range from 10 to 500 ng/mL. Fatal cases have shown blood concentrations in the range of 500 to 2000 ng/mL, often in combination with other substances.
Hair Follicle Detection
Hair testing for MXE has been validated using LC-MS/MS methods, with detection windows up to 90 days. The basic, lipophilic nature of the compound supports adequate hair incorporation. Several forensic laboratories have published validated methods for MXE in hair.
Confirmatory Methods
LC-MS/MS is the preferred confirmatory method. The analytical panel should include MXE and its primary metabolites (O-desmethylmethoxetamine and normethoxetamine). GC-MS is also applicable. Reference standards are widely available. Several peer-reviewed methods have been published and validated for clinical and forensic use.
Reagent Testing
The Marquis reagent produces no reaction with MXE. The Mandelin reagent produces a yellow to orange color. The Mecke reagent produces a yellow to brown response. The Morris reagent produces a characteristic color change with arylcyclohexanone compounds. These reagent profiles can help distinguish MXE from other drug classes but cannot differentiate it from structurally similar dissociatives.
Interactions
| Substance | Status | Note |
|---|---|---|
| Alcohol | Dangerous | — |
| Desomorphine | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| GBL | Dangerous | — |
| GHB | Dangerous | — |
| Naloxone | Dangerous | Both cause respiratory depression and unconsciousness; vomiting while dissociated risks aspiration |
| Opioids | Dangerous | — |
| 3-Cl-PCP | Caution | Compounding dissociative effects can cause confusion, mania, and loss of motor control |
| 3-HO-PCE | Caution | Compounding dissociative effects can cause confusion, mania, and loss of motor control |
| 3-HO-PCP | Caution | Compounding dissociative effects can cause confusion, mania, and loss of motor control |
| 3-MeO-PCE | Caution | Compounding dissociative effects can cause confusion, mania, and loss of motor control |
| 3-MeO-PCMo | Caution | Compounding dissociative effects can cause confusion, mania, and loss of motor control |
| 2-FA | Uncertain | — |
| 2-FMA | Uncertain | — |
| 25x-NBOMe | Uncertain | — |
| 2C-T-x | Uncertain | — |
| 3-FA | Uncertain | — |
History
Design and Origins
MXE was designed by a chemist with a pharmacological background — the compound is a deliberate structure-activity modification of ketamine, incorporating a 3-methoxy group (from 3-MeO-PCP's structure) and an N-ethyl group (from PCE), creating a novel compound intended to avoid scheduled drug laws while producing ketamine-like effects. This design approach represented a sophisticated understanding of SAR and marked MXE as qualitatively different from purely opportunistic analog synthesis.
The MXE Era (2011–2013)
MXE appeared on the UK research chemical market around 2010–2011 and rapidly developed a devoted following. It was unique among research chemicals of its period in generating consistently positive reviews for its experiential quality — community members frequently described it as superior to ketamine in depth and aftereffect. A community of dedicated users developed around MXE, generating extensive documentation of use practices, experiences, and harm reduction insights.
Scheduling and Decline
In April 2012, the UK government issued an emergency temporary class drug order for MXE — the first such order under the Misuse of Drugs Act — in response to reports of harms and the compound's growing popularity. MXE was subsequently permanently controlled in the UK, and other jurisdictions followed. This ended legitimate availability for most users.
Legacy
MXE's legacy is substantial in the dissociative community. It established a standard against which other dissociatives are measured, generated pharmacological insights about dual NMDA/SERT mechanisms, and its scheduling history influenced approaches to novel psychoactive substance legislation in multiple countries. The "hole" produced by MXE is frequently referenced in community discussions of the deep dissociative state as a benchmark experience.
Harm Reduction
MXE as a Historical Reference
MXE is no longer widely available. Vendors selling "MXE" in current markets are selling other compounds — often DCK, 2-FDCK, or other analogs. Verify any substance claimed to be MXE with reagent testing (Marquis, Mandelin) and fentanyl test strips.
Harm Reduction for Any Available MXE
If genuine MXE is encountered:
- Active doses are 10–25 mg insufflated (threshold), 25–75 mg common range
- Allow full duration (3–5 hours) before any consideration of redosing
- The intense, emotionally complex character warrants a secure, comfortable setting
- Sober companion for deeper doses
- Have a benzodiazepine available for overwhelming experiences
Renal Monitoring
Unlike other dissociatives where bladder monitoring is the primary focus, MXE additionally required monitoring for kidney function. Symptoms of renal stress (back/flank pain, dark urine, reduced urine output, edema) should prompt immediate medical evaluation.
Serotonergic Interactions
Do not combine MXE (or anything sold as MXE) with MAOIs, SSRIs, SNRIs, or other serotonergic drugs without understanding the serotonin syndrome risk. This is a meaningful distinction from other dissociatives.
The Compulsive Use Risk
Community accounts of MXE suggest its unusually rewarding character made it particularly prone to compulsive use. Frequency limits and clear decision-making about use occasions are especially important for this compound.
Toxicity & Safety
Cerebellar Toxicity
MXE produced a distinctive neurological toxicity not prominent with ketamine: cerebellar dysfunction causing pronounced ataxia, loss of coordination, and difficulty walking. This was documented across multiple case reports and community accounts, often at doses that produced the desired dissociative experience. Recovery was typically complete with abstinence, but the experience was alarming and could lead to falls and injuries.
Renal Toxicity
MXE was associated with reports of kidney damage — distinct from the bladder toxicity typical of ketamine. Case reports documented acute kidney injury in some heavy users. This nephrotoxicity risk represents an important toxicity concern beyond the bladder-focused harm reduction typical of ketamine analogs. Mechanism is not fully established but likely involves metabolic processing of MXE producing nephrotoxic metabolites.
Bladder Toxicity
As an arylcyclohexylamine, bladder toxicity risk is also present with regular use.
Psychological Risks
The intensely immersive and emotionally potent character of MXE experiences carried meaningful risks of difficult experiences, integration challenges, and psychological dependence. The emotional depth and music-enhancement qualities also made it particularly prone to compulsive use patterns.
Drug Interactions
MXE's SERT inhibition introduces potential for serotonin syndrome when combined with MAOIs or serotonergic drugs — a meaningful risk distinct from ketamine and many other NMDA antagonists.
Addiction Potential
moderately addictive with a high potential for abuse
Overdose Information
Overdose on Methoxetamine can range from unpleasant to life-threatening depending on the dose, route, and whether other substances are involved.
Signs of overdose: Severe nystagmus, complete unresponsiveness, vomiting (aspiration risk while unconscious), severely depressed breathing, seizures, extremely elevated heart rate or blood pressure.
Critical dangers:
- Respiratory depression: Particularly when combined with other depressants
- Aspiration: Loss of protective reflexes combined with nausea creates choking risk
- Hyperthermia or hypothermia: Impaired thermoregulation at high doses
Emergency response: Place the person in the recovery position. Monitor breathing. Call emergency services if breathing is slow, shallow, or irregular; if the person is unresponsive to stimulation; or if seizures occur. Be honest with medical personnel about what was consumed — they are there to help, not to judge.
Dangerous Interactions
The combinations listed below may be life-threatening. Independent research should always be conducted to ensure safety when combining substances.
Tolerance
| Full | develops with prolonged and repeated use |
| Half | 3 - 7 days |
| Zero | 1 - 2 weeks |
Cross-tolerances
Legal Status
In September 2014, the European Council decided that methoxetamine shall be subjected by the Member States to control measures and criminal penalties by October 2, 2015.
Austria: Since June 26, 2019, MXE is illegal to possess, produce and sell under the SMG. (Suchtmittelgesetz Österreich)
Brazil: Possession, production and sale is illegal as it is listed on Portaria SVS/MS nº 344
Canada: Health Canada declared MXE a controlled substance, citing it as "considered an analogue of ketamine." The possession, production, and sale are illegal.
Cyprus: Methoxetamine was listed in the drug control law in 2012.
Denmark: Methoxetamine is covered by the Executive Order on Euphoriant Substances.
Italy: According to the table of drugs, MXE has been illegal in Italy since 2016.
Japan: MXE is a narcotic drug in Japan effective June 26th, 2016.
Netherlands: It is illegal to possess, produce, trasnport, import, export, or sell MXE.
Russia: It is illegal to possess, produce, or sell MXE.
Slovenia: MXE is a controlled substance (Official Gazette of RS No. 62/2013).
Turkey: Methoxetamine is regulated under the Law on Control of Narcotics no. 2313.
Responsible use
Research chemical
Ketamine
MXE (Wikipedia)
MXE (Erowid Vault)
MXE (Isomer Design)
Discussion
The Big & Dandy Methoxetamine Thread (Bluelight)
Morris, H., & Wallach, J. (2014). From PCP to MXE: A comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis, 6(7–8), 614–632. https://doi.org/10.1002/dta.1620
Halberstadt, A. L., Slepak, N., Hyun, J., Buell, M. R., & Powell, S. B. (2016). The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents. Psychopharmacology, 233(7), 1215-1225. https://doi.org/10.1007/s00213-016-4203-3
Experience Reports (1)
Tips (4)
Weigh your dose of Methoxetamine with a milligram scale. Dissociative dose-response curves are steep. The difference between a pleasant floaty experience and complete dissociation from reality can be 50mg or less.
The moreish quality of many dissociatives including Methoxetamine makes compulsive redosing common. Pre-measure your intended dose and put the rest away. A timed lockbox can help prevent impulsive additional doses.
Test Methoxetamine with appropriate reagent kits. Dissociative powders are frequently mislabeled or adulterated. A Mandelin reagent test helps distinguish between some common dissociatives. Always use fentanyl test strips as well.
Frequent use of Methoxetamine can cause urinary tract and bladder damage. If you notice increased urinary frequency, urgency, pain, or blood in urine, stop using immediately. This damage can become permanent.
See Also
References (4)
- Ketamine as a rapid antidepressant — Berman et al. Biological Psychiatry (2000)paper
- PubChem: Methoxetamine
PubChem compound page for Methoxetamine (CID: 52911279)
pubchem - Methoxetamine - TripSit Factsheet
TripSit factsheet for Methoxetamine
tripsit - Methoxetamine - Wikipedia
Wikipedia article on Methoxetamine
wikipedia